ORLANDO, Florida,, April 4, 2011 /PRNewswire/ -- Berg Diagnostics, a member of the Berg Pharma, Inc group of companies with Berg Biosystems and Cytotech Labs, is a Boston-based molecular diagnostics company that officially launched its molecular diagnostics services and products at AACR meeting from April 2nd - 6th in Orlando, Florida.

COVENTRY, England, April 4, 2011 /PRNewswire/ -- Lloydspharmacy, the community pharmacy chain, has revealed that one in four* (24%) of the population in Great Britain - or 11 million** adults - has taken or applied medicines which they later discovered were out of date.

Lloydspharmacy found that more than half (53%) of people do not always check the expiry date of medicines before taking them or giving them to a family member.

This is worrying considering that nearly one in six people (17%) never clear out their medicine cabinets. It presents the risk of expired medicines being used when they are no longer deemed safe. Many medicines become ineffective when they pass their expiry date and could also cause harm if they are taken by someone they were not intended for.

CRAIGAVON, Northern Ireland, April 4, 2011 /PRNewswire/ -- Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd, announce the first publication describing a potential new anti-angiogenic therapy based on a natural protein first discovered at QUB. Anti-angiogenics prevent the growth of new blood vessels in tumours and starve them of nutrients, leading to inhibition of tumour growth. 

ORLANDO, Florida, April 4, 2011 /PRNewswire/ -- Miltenyi Biotec today announces the worldwide release and availability of the MACSQuant(R) VYB, a compact, benchtop flow cytometer featuring violet, yellow, and blue lasers, and detection of 10 optical parameters. The MACSQuant VYB enables easy but sophisticated multiparametric analysis of fluorescent protein-expressing cells, stem cell characterization, and much more. With this launch, the leading provider of tools and services for cell separation and analysis technologies extends the scope and power of its flow cytometry business.

NEW ORLEANS, April 3, 2011 /PRNewswire/ -- Abbott today announced positive one-year results from 101 patients enrolled in the second phase of the ABSORB trial evaluating the world's first drug eluting Bioresorbable Vascular Scaffold (BVS) for the treatment of coronary artery disease. These results were presented during the American College of Cardiology's (ACC) 60th Annual Scientific Session and i2 Summit 2011 in New Orleans.

Fisherfolk can be tremendous founts of information about marine animals. They know where to find different species, what sort of baits they like best, what sizes to expect, and how all these things change with the seasons. Smart marine biologists spend a lot of time talking with fishers and learning from them.

That said, fishers can sometimes draw rather curious conclusions from what they observe. Here's an excerpt from a recent article by well-known angler and fishing writer Charley Soares:

ORLANDO, Florida, April 4, 2011 /PRNewswire/ -- Cytotech Labs, a Boston based pharmaceutical company and member of the Berg Pharma, Inc. group along with Berg Biosystems and Berg Diagnostics today presented groundbreaking insight into seminal work performed by Nobel Laureate, Otto Warburg. The Warburg Hypothesis asserts that increased utilization of anaerobic respiration and production of lactate is negotiated by cancer cells in return for evasion of apoptosis, programmed cell death and other key characteristics of a healthy cell such as normally functioning mitochondria, the cell's energy and metabolic headquarters. This area of research has become of intense importance to medical research in the past decade for many disease states.

DUBAI, UAE, April 3, 2011 /PRNewswire/ -- As GCC countries approach their stiflingly hot summer months, the matter of cooling people, places and businesses will be at the forefront of everybody's mind. New technologies to keep cool come and go, but one in particular has become increasingly popular within mixed-use developments within this region.

District cooling requires a network of water, pipes, cooling plants and innovative technology to pump air conditioning into buildings, developments and even metro networks.

The question usually asked is why choose district cooling over your usual run of the mill air conditioner when it costs more to implement initially?

Some days I wonder if we were set up from the get-go to expect less, to hope for less, to dream of less. My son's prognosis was grim and bitter to the heart when he was a tender five. And yet here he is at 21 continually amazing us with the strides he makes.

The public perception of autism continues to be one of grim stereotypes. Certainly there is a sizable minority edging to the halfway mark of moderately to severely disabled autistic individuals; this appears to be what the general public pictures when they hear the word autism. Just as certain is that my three children aren't there; they aren't severely disabled, not now, but once upon a time, my son was much more severely impacted so that many standardized tests placed him in the first percentile.

I have recently dusted off an algorithm I had invented eight years ago, one I dubbed "Hyperball algorithm". It might come handy for predicting the b-tagging rate in CMS events with jets, for an analysis I am thinking of doing. Since saying more would violate a dozen rules so let's leave it at that, and let me instead describe the old idea... Just for fun.

Predictions for the Higgs at the Tevatron